Projected Income Statement: CSL Limited

Forecast Balance Sheet: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 -779 10,679 10,526 8,981 9,383 8,933 8,465 7,827
Change - 1,470.86% -1.43% -14.68% 4.48% -4.8% -5.24% -7.54%
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 1,079 1,228 849 636 646 912.2 1,012 1,040
Change - 13.83% -30.86% -25.09% 1.57% 41.2% 10.97% 2.77%
Free Cash Flow (FCF) 1 1,550 1,373 1,915 2,925 2,866 3,129 2,938 3,093
Change - -11.41% 39.48% 52.74% -2.02% 9.18% -6.11% 5.29%
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 34.04% 29.3% 32.09% 33.11% 28.09% 32.18% 32.54% 32.82%
EBIT Margin (%) 27.72% 23.06% 25.76% 28.72% 29.25% 27.79% 28.18% 28.41%
EBT Margin (%) 26.32% 20.01% 22.8% 23.94% -25.87% 23.45% 25.2% 25.58%
Net margin (%) 21.35% 16.48% 17.85% 19.3% -16.33% 18% 19.41% 19.81%
FCF margin (%) 14.67% 10.32% 12.94% 18.8% 18.14% 19.85% 18.01% 18.2%
FCF / Net Income (%) 68.74% 62.58% 72.48% 97.44% -111.13% 110.29% 92.8% 91.86%

Profitability

        
ROA 9.7% 6.79% 7.12% 7.75% -7.06% 10.31% 10.45% 10.5%
ROE 19.64% 14.45% 15.94% 16.36% -15.11% 19.16% 18.77% 18.37%

Financial Health

        
Leverage (Debt/EBITDA) - 2.74x 2.22x 1.74x 2.11x 1.76x 1.59x 1.4x
Debt / Free cash flow - 7.78x 5.5x 3.07x 3.27x 2.85x 2.88x 2.53x

Capital Intensity

        
CAPEX / Current Assets (%) 10.21% 9.23% 5.74% 4.09% 4.09% 5.79% 6.21% 6.12%
CAPEX / EBITDA (%) 30% 31.49% 17.87% 12.35% 14.56% 17.98% 19.07% 18.64%
CAPEX / FCF (%) 69.6% 89.44% 44.33% 21.74% 22.54% 29.15% 34.45% 33.63%

Items per share

        
Cash flow per share 1 5.592 5.375 5.697 7.324 7.287 7.369 7.976 8.4
Change - -3.87% 5.98% 28.56% -0.51% 1.13% 8.24% 5.31%
Dividend per Share 1 2.22 2.36 2.64 2.92 2.92 3.001 3.182 3.408
Change - 6.31% 11.86% 10.61% 0% 2.76% 6.04% 7.12%
Book Value Per Share 1 30.26 32.73 35.93 39.93 30.9 33.71 36.81 40.43
Change - 8.14% 9.79% 11.14% -22.62% 9.1% 9.21% 9.82%
EPS 1 4.8 4.53 5.45 6.17 -5.35 6.1 6.723 7.055
Change - -5.62% 20.31% 13.21% -186.71% 214.02% 10.22% 4.93%
Nbr of stocks (in thousands) 481,706 482,372 483,253 484,212 478,912 478,912 478,912 478,912
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD
Estimates
2027 *2028 *
P/E 20.6x 18.7x
PBR 3.73x 3.42x
EV / Sales 4.39x 4.21x
Yield 2.39% 2.53%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
125.78USD
Average target price
122.21USD
Spread / Average Target
-2.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CSL Stock
  4. Financials CSL Limited